Comparative effects of weight loss and incretin‐based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial-Reference-Cited by-同舟云学术

Comparative effects of weight loss and incretin‐based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial

Published:2022-11-10 Issue:2 Volume:25 Page:570-580
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Mashayekhi Mona¹^ORCID,Beckman Joshua A.²^ORCID,Nian Hui³,Garner Erica M.¹,Mayfield Dustin⁴,Devin Jessica K.⁵,Koethe John R.⁶⁷,Brown Jonathan D.⁸,Cahill Katherine N.⁹,Yu Chang¹⁰,Silver Heidi⁶¹¹,Niswender Kevin¹⁶,Luther James M.⁴,Brown Nancy J.¹²

Affiliation:

1. Department of Medicine, Division of Diabetes, Endocrinology and Metabolism Vanderbilt University Medical Center Nashville Tennessee

2. Department of Medicine, Division of Vascular Medicine UTSouthwestern Dallas Texas

3. Department of Biostatistics Vanderbilt University Medical Center Nashville Tennessee

4. Department of Medicine, Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville Tennessee

5. UCHealth Endocrinology, Yampa Valley Medical Center Steamboat Springs Colorado

6. Veterans Affairs Tennessee Valley Healthcare System Nashville Tennessee

7. Department of Medicine, Division of Infectious Diseases Vanderbilt University Medical Center Nashville Tennessee

8. Department of Medicine, Division of Cardiovascular Medicine Vanderbilt University Medical Center Nashville Tennessee

9. Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine Vanderbilt University Medical Center Nashville Tennessee

10. Department of Population Health NYU Grossman School of Medicine New York New York

11. Department of Medicine, Division of Gastroenterology Vanderbilt University Medical Center Nashville Tennessee

12. Yale School of Medicine New Haven Connecticut

Funder

American Heart Association

National Center for Advancing Translational Sciences

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14903

Reference48 articles.

1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

3. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

4. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

5. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efectos cardiometabólicos de la pérdida de peso;Atención Primaria;2024-10

2. Liraglutide’s Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis;Endocrine Practice;2024-08

3. Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future;Biomedicines;2024-06-21

4. Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials;Diabetology & Metabolic Syndrome;2024-06-14

5. Effect of GLP-1RA Treatment on Adhesion Molecules and Monocyte Chemoattractant Protein-1 in Diabetic Patients with Atherosclerosis;Life;2024-05-28